Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guilherme de Jesus

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2024
ReplyMedha Barbhaiya, Stephane Zuily, Guilherme de Jesus, et al.
Journal of Strength and Conditioning Research|April 23, 2019
Dietary Strategies of Modern Bodybuilders During Different Phases of the Competitive CycleJaqueline L Lenzi, Emerson L Teixeira, Guilherme de Jesus, et al.
Perceptual and Motor Skills|June 20, 2025
The Acute Effects of Short- and Long-Duration CrossFit® Session on Tissue Damage, Autonomic Response, and Fatigue: A Crossover StudyRamon Toledo, Marcelo Ricardo Dias, João Guilherme Vieira, et al.
Autoimmunity Reviews|January 3, 2024
Deciphering the clinical significance of longitudinal antiphospholipid antibody titersCecilia B Chighizola, Rohan Willis, Gabriella Maioli, et al.
Arthritis Care & Research|November 30, 2020
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate CriteriaMedha Barbhaiya, Stephane Zuily, Yasaman Ahmadzadeh, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repositoryMaria Efthymiou, Ian J Mackie, Philip J Lane, et al.
Clinical and Experimental Rheumatology|July 30, 2025
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryJheel Pandya Bhatt, Marissa Dale, Danieli Castro Oliveira de Andrade, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2024
ReplyMedha Barbhaiya, Stephane Zuily, Guilherme de Jesus, et al.
Journal of Strength and Conditioning Research|April 23, 2019
Dietary Strategies of Modern Bodybuilders During Different Phases of the Competitive CycleJaqueline L Lenzi, Emerson L Teixeira, Guilherme de Jesus, et al.
Perceptual and Motor Skills|June 20, 2025
The Acute Effects of Short- and Long-Duration CrossFit® Session on Tissue Damage, Autonomic Response, and Fatigue: A Crossover StudyRamon Toledo, Marcelo Ricardo Dias, João Guilherme Vieira, et al.
Autoimmunity Reviews|January 3, 2024
Deciphering the clinical significance of longitudinal antiphospholipid antibody titersCecilia B Chighizola, Rohan Willis, Gabriella Maioli, et al.
Arthritis Care & Research|November 30, 2020
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate CriteriaMedha Barbhaiya, Stephane Zuily, Yasaman Ahmadzadeh, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repositoryMaria Efthymiou, Ian J Mackie, Philip J Lane, et al.
Clinical and Experimental Rheumatology|July 30, 2025
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryJheel Pandya Bhatt, Marissa Dale, Danieli Castro Oliveira de Andrade, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Pageof 1